Synonyms: | |
Status: | Approved (2020) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC35 |
UNII: | QQA9MLH692 |
Action | Mechanism of Action | Reference |
---|---|---|
BINDING AGENT | B-lymphocyte antigen CD19 binding agent | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Lymphoma | 4 | D008223 | ClinicalTrials |
Lymphoma, Large B-Cell, Diffuse | 4 | D016403 | FDA |
Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
Lymphoma, Follicular | 3 | D008224 | ClinicalTrials |
Leukemia, Prolymphocytic | 2 | D015463 | ClinicalTrials |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
Lymphoma, Non-Hodgkin | 2 | D008228 | ClinicalTrials |
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4298047 |
FDA SRS | QQA9MLH692 |